AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease

Thursday, AbbVie scored its seventh FDA approval for Rinvoq in a span of less than four years, getting the JAK inhibitor across the finish line as a treatment for Crohn’s disease.